Skip to main content

Advertisement

Advertisement

Austria says blood plasma cures several coronavirus patients

VIENNA — Austria said Thursday (May 7) that several Covid-19 patients were cured after receiving transfusions using blood plasma from people who had recovered from the virus.

Convalescent plasma has proven effective in small studies to treat infectious diseases including Ebola and Sars.

Convalescent plasma has proven effective in small studies to treat infectious diseases including Ebola and Sars.

Follow TODAY on WhatsApp

VIENNA — Austria said Thursday (May 7) that several Covid-19 patients were cured after receiving transfusions using blood plasma from people who had recovered from the virus.

Three patients who had transfusions at a hospital in the southeastern city of Graz are now cured, Mr Robert Krause, an infectious disease specialist at the hospital told a press conference. 

However, it is "an option for hand-picked patients and is not readily transferable" to anyone who falls sick with the virus, he said. 

Two of the three patients had other diseases and very weakened immune systems. 

A total of 20 people have been treated in Austria with the therapy, which uses part of the blood rich in antibodies, known as convalescent plasma, from Covid-19 patients. 

The Red Cross launched an urgent appeal to plasma donors on Thursday to allow this therapy, which is still experimental, to be tested more widely. 

Some 200 donations have so far been made in Austria.

Convalescent plasma has proven effective in small studies to treat infectious diseases including Ebola and Sars.

Its use to treat Covid-19 patients has been authorised in other countries such as France, the United States, Switzerland and China. AFP

Related topics

Covid-19 coronavirus plasma treatment

Read more of the latest in

Advertisement

Advertisement

Stay in the know. Anytime. Anywhere.

Subscribe to get daily news updates, insights and must reads delivered straight to your inbox.

By clicking subscribe, I agree for my personal data to be used to send me TODAY newsletters, promotional offers and for research and analysis.